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Glucocorticoids are lipid-soluble hormones that
signal via the glucocorticoid receptor (GR), a ligand-
dependent transcription factor. Circulating glucocor-
ticoids derive from the adrenals, but it is nowapparent
that paracrine glucocorticoid signaling occurs in
multiple tissues. Effective local glucocorticoid con-
centrations and whether glucocorticoid delivery can
be targeted to specific cell subsets are unknown.
We use fluorescence detection of chromatin-associ-
atedGRs asbiosensors of ligandbinding and observe
signals corresponding to steroid concentrations over
physiological ranges in vitro and in vivo. In the
thymus, where thymic epithelial cell (TEC)-synthe-
sized glucocorticoids antagonize negative selection,
we find that CD4+CD8+TCRhi cells, a small subset
responding to self-antigens and undergoing selec-
tion, are specific targets of TEC-derived glucocorti-
coids and are exposed to 3-fold higher levels than
other cells. These results demonstrate and quantitate
targeted delivery of paracrine glucocorticoids. This
approach may be used to assess in situ nuclear re-
ceptor signaling in a variety of physiological and path-
ological contexts.INTRODUCTION
Glucocorticoids are adrenal-derived steroid hormones that
are required for organismal development and homeostasis.
Glucocorticoids function primarily as the activating ligand of
the glucocorticoid receptor (GR), a ubiquitously expressed
ligand-dependent transcription factor. Glucocorticoid binding
to the cytosolic GR induces a change in GR conformation,
release from chaperone proteins, exposure of a nuclear localiza-
tion sequence, and trafficking to the nucleus. In the nucleus,
liganded GR forms homodimers and homotetramers, and binds
to specific DNA sequences in gene promoters to initiate or
repress gene expression, either directly as a bona fide transcrip-
tion factor or by interacting with and regulating other transcrip-This is an open access article under the CC BY-Ntion factors (Presman et al., 2014). Whereas high physiological
ligand concentrations drive nearly all GRs to the nucleus (Stav-
reva et al., 2009), only 20%–45% of the nuclear-localized GR is
estimated to be bound to chromatin at any given time (Paaki-
naho et al., 2017).
Most research regarding glucocorticoids in vivo has dealt
with the circulating hormone, which is derived from the
adrenals. There is, however, a growing appreciation that gluco-
corticoids are synthesized by a large number of extra-adrenal
tissues, and that this tissue-specific production is critical for
local control of immune activation (Noti et al., 2009; Taves
et al., 2011a). An example of the importance of tissue-specific
GR signaling is the thymus, in which the GR is required for
generation of competent T cells, which orchestrate adap-
tive immunity. Glucocorticoids dampen the consequences of
signaling by T cell antigen receptors (TCRs) with high affinity
for self-antigens, allowing cells that would otherwise undergo
apoptotic death (negative selection) to survive and become
mature T cells (positive selection) (Mittelstadt et al., 2012,
2018). Within the thymus, glucocorticoids are produced by
thymic epithelial cells (TECs) (Vacchio et al., 1994; Lechner
et al., 2000), and in early life this local synthesis can result in
a higher local glucocorticoid level than in the blood (Schmidt
and Soma, 2008; Taves et al., 2015, 2016a). The importance
of locally derived glucocorticoids was demonstrated by dele-
tion of the terminal enzyme in de novo glucocorticoid biosyn-
thesis, Cyp11b1, in TECs. Despite normal circulating gluco-
corticoid levels, antigen-specific thymocyte development was
altered in a manner similar to that in mice whose thymo-
cytes lack the GR and are therefore unable to respond to
glucocorticoids (Mittelstadt et al., 2018). TEC-derived gluco-
corticoids are thus critical for immunocompetence. Dissecting
the mechanism of paracrine and autocrine glucocorticoid
signaling in the thymus and other tissues, however, has been
obstructed by the inability to measure steroid signaling with
high resolution. Currently, two main approaches are used to
examine tissue steroid signaling: (1) direct measurement of
total tissue steroids, and (2) measurement of steroid-depen-
dent responses. Direct measurement of local steroid levels
(e.g., in rapidly collected and frozen tissue samples) has excel-
lent temporal resolution, but the highest spatial resolution is
currently obtained from dissected (Amateau et al., 2004; Croft
et al., 2008; Prior et al., 2013; Tobiansky et al., 2018) or wholeCell Reports 26, 3629–3642, March 26, 2019 3629
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Simultaneous Permeabilization and
Fixation Preferentially Retains the Liganded
Glucocorticoid Receptor
(A) 3617 mouse mammary adenocarcinoma cells
expressing a GFP-tagged glucocorticoid receptor
(GR) were incubated in the absence or presence of
the GR ligand corticosterone for 15 min. Cells were
then kept on ice (Live), fixed with 2% para-
formaldehyde in fluorescence-activated cell sorting
(FACS) buffer (Fix only), or fixed with 0.5% Triton
X-100 and 2% paraformaldehyde in FACS buffer
(Perm-fix). Cells were washed and GFP-GR quan-
tified by flow cytometry. Histograms are represen-
tative of two independent experiments.
(B) Relative increase in GR content of GFP-GR 3617
cells upon addition of corticosterone, after perm-fix
with various buffers. Data are geometric means of
two independent experiments ± geometric SD.
Cort, corticosterone; MFI, median fluorescence
index; Triton, Triton X-100.
See also Figure S1.(Taves et al., 2015, 2016a) organ samples, from which total
steroid content is extracted and selected steroids measured
by immunoassays or mass spectrometry. These approaches
thus obtain aggregate measures of steroid concentrations
averaged over thousands or millions of cells and extracellular
material, and may not reflect the bioavailable steroid frac-
tion. Mass spectrometry imaging may offer improved spatial
specificity for high-concentration analytes (Cobice et al.,
2013), but still provides similar averaged values. In contrast,
measurement of steroid responses can have excellent spatial
resolution, but at the cost of specificity and temporal resolu-
tion. Steroid-dependent gene expression in particular can be
measured in single cells, but such responses are cell specific
and context dependent (Weikum et al., 2017), and mRNA
decay may take many hours (Yang et al., 2003). Across tissues,
therefore, it remains unknown which cell subsets are signaled
by glucocorticoids, whether paracrine glucocorticoid delivery
is targeted, and what concentrations cells within an organ
are exposed to.
Detection of numerous signaling molecules has advanced
greatly with the development of biosensors, which transform
biochemical information into analytically useful signals (Thévenot
et al., 2001). Fluorescent biosensors, for example, allow imaging
and quantification in living cells with high spatial and temporal
resolution, andare used to detect the activity of signaling interme-
diates suchascAMP,glutamate, tryptophan, andCa2+ (VanEnge-
lenburg and Palmer, 2008). They can also be used to detect the
activities of proteins such as GTPases (Mochizuki et al., 2001),
kinases (Wang et al., 2005), and caspases (Zhang et al., 2013).
We hypothesized that ligand-dependent association with nuclear3630 Cell Reports 26, 3629–3642, March 26, 2019chromatin might allow us to selectively
detect occupiedGRs, thus allowing endog-
enous GRs to function as biosensors for
their ligand.Here,weusedchromatin-asso-
ciated GR for single-cell detection and
quantification of glucocorticoid signaling,
identifying targeted delivery of TEC-derivedglucocorticoids to a small subset of thymocytes undergoing anti-
gen-specific selection.
RESULTS
Simultaneous Permeabilization and Fixation
Preferentially Retains the Liganded GR
It is difficult to distinguish between biologically active and inactive
GRs at the single-cell level. Because ligandbinding stimulatesGR
interaction with DNA, and because protein-DNA interactions are
effectively stabilized by formaldehyde cross-links (Hoffman et al.,
2015), we hypothesized that a combination of cross-linking and
detergent permeabilization would retain liganded, chromatin-
bound GR molecules and remove unliganded, freely diffusing
GRs. Measurement of GR retention would thus provide a specific
biosensor of ligand-dependent activation and could be applied as
a cell-specific readout of glucocorticoid exposure. Permeabiliza-
tion and fixation conditions were tested using 3617 mouse mam-
mary adenocarcinoma cells that stably express a GFP-tagged
GR (Presman et al., 2014). Cells were cultured for 15 min in ste-
roid-free medium or medium containing the natural glucocorti-
coid corticosterone, and GFP-GR levels were assessed by flow
cytometry. As expected, corticosterone treatment had no effect
on GFP-GR levels in living cells or cells fixed with 2%paraformal-
dehyde (‘‘Fix only’’) (Figure 1A). Sequential permeabilization and
then fixation has been used to selectively retain DNA replication
proteins (Forment and Jackson, 2015), and although this
approach did result in a corticosterone-dependent increase
in GFP-GR, >90% of GFP-GR fluorescence was lost and the re-
maining signal was extremely low (Figure S1A). In contrast,
simultaneous permeabilization and fixation with 0.5% Triton
X-100 and 2% paraformaldehyde (‘‘Perm-fix’’) resulted in a
ligand-dependent increase in GFP-GR levels compared with
vehicle control and much better GFP-GR retention in the pres-
ence or absence of ligand (Figure 1A; Figures S1A and S1B).
Sequential permeabilization and fixation may be more suitable
for chromatin-cross-linking of replication proteins that have rela-
tively longDNAdwell times (e.g., PCNA) (Ha et al., 2012), whereas
simultaneous permeabilization-fixation may be required for chro-
matin-cross-linking of transcription factors that have shorter DNA
dwell times (e.g., GR) (Paakinaho et al., 2017). Varying both the
formaldehyde and detergent concentrations revealed that higher
formaldehyde concentrations had to be accompanied by stron-
ger permeabilization to give the same ligand-dependent GR
retention (Figure 1B). This presumably reflects the need for an
optimal balance between the speed of GR fixation and the time
it takes for unliganded GR to be washed from the cell, and
this balance likely differs between proteins depending on their
chromatin-binding characteristics. Methanol-containing formal-
dehyde andmethanol-free formaldehyde were both suitable (Fig-
ure S1C). Interestingly, the commercial BD Cytofix/Cytoperm
(‘‘Cytofix’’) buffer behaved identically to fix-only, whereas the
commercial eBioscience FoxP3 transcription factor buffer set




Chemically cross-linked GR could become resistant to washing
out by forming large higher-order structures or protein aggre-
gates, or by tethering to adjacent chromatin (Hoffman et al.,
2015). To first test whether perm-fix specifically retains nuclear
and not cytosolic GR, we examined GFP-GR-expressing 3617
cells using imaging flow cytometry, which combines flow cytom-
etry with fluorescence microscopy. In the absence of glucocor-
ticoids, the GR was primarily found in the cytosol of live cells,
but after corticosterone treatment it was largely nuclear (Fig-
ure 2A, Live). Nuclear GR translocation after corticosterone
treatment was especially clear in fixed cells, as shown by GFP
colocalization with DAPI-stained nuclei (Figure 2A, Fix only). In
contrast, although little GR was retained after perm-fix of un-
treated cells, there was easily detectable GFP-GR in the nuclei
of corticosterone-treated cells (Figure 2A, Perm-fix). Quantifica-
tion of nuclear GFP-GR by the GFP/DAPI similarity score (see
STAR Methods) showed a similar frequency of nuclear translo-
cation in fixed and perm-fixed cells (Figure 2A, right). Because
only a minority of nuclear-localized GR is chromatin bound at
any given time (Paakinaho et al., 2017), if perm-fix primarily
cross-links DNA and/or protein-associated GR, the majority
should be lost even after corticosterone treatment. Indeed, as
judged by immunoblotting, treatment with corticosterone pre-
served GR compared with medium alone, but it was much
reduced compared with cells that were not perm-fixed (Fig-
ure 2B). Loss of actin after perm-fix was similar with or without
corticosterone, whereas nuclear histone H3 was retained in
both live and perm-fixed cells regardless of corticosterone treat-
ment, showing that the effect of glucocorticoid treatment was
specific to its receptor.A specific role for chromatin binding in perm-fix GR retention
was indirectly evaluated by incubating 3617 cell lines expressing
no GR (KO), wild-type GR (GRwt), or a dimerization-impaired
mutant GR (GRmon) that translocates to the nucleus upon gluco-
corticoid treatment, but only at very high concentrations does it
associate with chromatin (Presman et al., 2014). Glucocorticoid
treatment did not alterGFP-GRwt orGFP-GRmon levels in live cells
as evaluated by flow cytometry (Figure 2C), but a 1,000-fold
higher dose was needed for GRmon retention after perm-fix (Fig-
ure 2D). The possible requirement for an interaction with chro-
matin in GR retention was directly tested using HEK293T cells
expressing GFP-GRwt (Presman et al., 2014) or a GR mutant
(GFP-GRC440G) in which the C440G substitution in the DNA bind-
ing domain reduces the affinity for cognate DNA binding sites
(Paakinaho et al., 2017). The dose-response of GR retention
was similar at lower concentrations of corticosterone, but GFP-
GRC440G levels plateaued at approximately 30 nM, whereas
GFP-GRwt continued to increase. To eliminate any possible
contribution of GFP-GRC440G heterodimerization with 293 cell’s
endogenous wild-type GR, a double mutant (GFP-GRC440G/mon)
incapable of dimerizing with itself or the endogenous GR was
introduced (Figure 2E). In this case, the entire dose-response
curve was shifted toward higher corticosterone levels. We there-
fore conclude that ligand-induced GR retention after perm-fix
largely reflects GR cross-linking to chromatin.
Use of Permeabilization-Fixation to Quantitate GR-
Chromatin Dissociation Kinetics
The GR dissociates from chromatin within 15 min of ligand
removal (Stavreva et al., 2009) but remains in the nucleus for
many hours (Liu and DeFranco, 2000). Thus, the rate at which
perm-fix retention of GR decreases after ligand removal should
reflect the fraction that is chromatin associated (half-life of mi-
nutes) versus simply nuclear (half-life of hours). We used the
perm-fix assay to determine the kinetics of GR dissociation
from chromatin after ligand withdrawal. GFP-GR 3617 cells
were treated with corticosterone for 15 min, washed, and incu-
bated in steroid-free medium at room temperature for different
times before perm-fix. After corticosterone removal, GR reten-
tion decreased with a t1/2 of 17 min (Figure 2F). Even 60 min after
removing glucocorticoids, the GR remained in the nucleus as
demonstrated by fix-only followed by imaging flow cytometry
(Figure 2G). In contrast, after perm-fix the GR was lost from
the cell. Thus, the rapid decrease of GR signal in perm-fixed cells
after ligand removal reflects a decrease in chromatin-associated
GR, not movement of the GR to the cytosol.
Cross-linking of Liganded Nuclear Receptors Quantifies
Ligand Exposure
The applicability of perm-fix as a generalizable means of detect-
ing liganded nuclear receptors was assessedwith 3617 cells that
stably express a variety of fluorescent protein-receptor fusion
products: GFP-androgen receptor (AR), mCherry (mCh)-estro-
gen receptor a (ER), GFP-GR, or GFP-progesterone receptor b
(PR) (Presman et al., 2016). Brief (15–30 min) incubation of the
cells with their corresponding steroid ligand had no effect on
receptor protein levels in live cells, as detected by flow cytometry
(Figure 3A; Figure S1E). Fix-only also resulted in little, if any, lossCell Reports 26, 3629–3642, March 26, 2019 3631
Figure 2. Permeabilization-Fixation Retains Chromatin-Associated GRs
(A) GFP-GR 3617 cells were treated with corticosterone, kept on ice (Live), fixed or perm-fixed, and data were acquired by imaging flow cytometry. DAPI staining
was used to define the nucleus after fix or perm-fix. Frequencies of GR+ nuclei were quantified using the similarity score algorithm included in the IDEAS analysis
software. Images are from cells with the median GFP/DAPI similarity score from each sample. Data are representative of three independent experiments. Scale
bar, 10 mm.
(B) GFP-GR 3617 cells were treated with corticosterone, perm-fixed, washed, diluted in SDS gel loading buffer, subjected to SDS-PAGE, and immunoblotted for
the indicated proteins. Blots are representative of two independent experiments.
(C and D) 3617 cells expressing the wild-type GR (GFP-GRwt), dimerization-impaired GR (GFP-GRmon), or deficient for GR (KO) were treated with different
concentrations of corticosterone, kept on ice (C), or perm-fixed (D), and data were acquired by flow cytometry. Data are representative of two independent
experiments.
(E) HEK293T cells were transfected with plasmids encoding the wild-type GR (GFP-GRwt), GR C440G mutant (GRC440G), which has reduced DNA binding, or the
GRC440G/mon double mutant. GFP+ cells were sorted, treated with different concentrations of corticosterone, and perm-fixed, and data were acquired by flow
cytometry. Live cells were untreated. Data are representative of three independent experiments.
(F) GFP-GR 3617 cells were treated with corticosterone for 15 min and then incubated in steroid-free medium for the indicated times and perm-fixed, and data
were acquired by flow cytometry. The GR MFI of cells perm-fixed in the presence of corticosterone was set to 100%, and the MFI of cells kept in steroid-free
medium was set to 0%. Data are means ± SEM of three independent experiments.
(G) GFP-GR 3617 cells were treated with corticosterone, incubated in steroid-free medium for 15 min, and perm-fixed, and data were acquired by imaging flow
cytometry. Data are representative of two independent experiments. Scale bar, 10 mm.
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of receptor fluorescence compared with live cells, confirming
that receptor proteins were not depleted with this approach. In
contrast, after perm-fix there was substantial receptor loss in
all groups, but much less so in the cells incubated with ligand
(Figure 3A). Of note, the unliganded ER is constitutively located
in the nucleus (Htun et al., 1999); therefore, ligand-specific reten-
tion of ER after perm-fix is consistent with preferential stabiliza-
tion of liganded and chromatin-associated receptors, not total
nuclear receptors. For all four receptors, dose-response studies
found that retention varied as a function of steroid dose (Fig-
ure 3B). The ligand-sensitive portions of the fluorescence curves
spanned endogenous steroid concentrations (Overk et al., 2013;
Taves et al., 2011b), and affinities (Kd) calculated from these data
were within the range of values previously determined using
competitive radioligand binding assays (Attardi and Ohno,
1976; Philibert and Raynaud, 1973; Reul and de Kloet, 1985;
Wasner et al., 1983; Yeakley et al., 1980). GFP-GR fluorescence
curves also corresponded with different ligand affinities (Fig-
ure 3C), as previously determined using competitive radioligand
binding assays (Munck and Brinck-Johnsen, 1968; Russo-Marie
et al., 1979). Thus, this approach could be useful for unbiased as-
sessments of nuclear receptor activity in response to a diverse
spectrum of ligands, known and potentially unknown.
Permeabilization-Fixation of Primary Cells Allows
Antibody Detection of Ligand-Activated GR
The use of fluorescent fusion proteins allowed us to explore the
relationship between GR occupancy and retention, but is not
applicable to normal tissues. We therefore asked whether GR
retention after perm-fix could be detected by antibody staining.
Initial experiments using corticosterone-treated GFP-GRwt,
GFP-GRmon, and GR-deficient 3617 cells showed that anti-GR
staining after perm-fix treatment closely paralleled GFP-GR fluo-
rescence as evaluated by flow cytometry (Figure S2A). Next, ex-
periments were performed with primary murine thymocytes from
wild-type and GRlck-Cre mice, which lack GR expression in thy-
mocytes (Mittelstadt et al., 2012). Surprisingly, two commonly
used anti-GR monoclonal antibodies, 5E4 and BuGR2, had
bright staining in GR-deficient thymocytes (70%–85% of wild-
type; Figure S2B, left and center), making their use problematic.
Another monoclonal antibody, G-5, hadmuch lower background
staining in GR-deficient thymocytes (30% of wild-type; Fig-
ure S2B, right) and was used in further studies. Corticosterone
treatment of GR-deficient or wild-type thymocytes had no effect
on GR levels as determined by staining after fix-only (Figure 4A,
left). However, as with GFP-GR 3617 cells, there was increased
GR staining of wild-type perm-fixed thymocytes after corticoste-Figure 3. Crosslinking of Liganded Nuclear Receptors Quantifies Liga
(A) 3617 cells expressing a GFP-androgen receptor, mCherry-estrogen receptor a
steroid ligands (testosterone, 17b-estradiol, corticosterone, or progesterone) an
cytometry. Horizontal axis scales are identical in stacked histograms of the sam
(B) 3617 cells expressing nuclear receptor fusion proteins were treated with vario
are representative of two independent experiments.
(C) GFP-GR 3617 cells were treated with different steroids, perm-fixed, and
experiments.
AR, androgen receptor; Bmax, maximum binding; ER, estrogen receptor a; GR, glu
index.
3634 Cell Reports 26, 3629–3642, March 26, 2019rone treatment (Figure 4A, right). Furthermore, detection of the
GR increase in glucocorticoid-treated, perm-fixed thymocytes
was found to be optimal under conditions similar to those used
with GFP-GR-expressing cells (Figure S2C). GR staining inten-
sity had a dose-dependent relationship with the concentration
of glucocorticoids in perm-fixed mouse thymocytes (Figure 4B)
and primary human T and B cells (Figure 4C). The results with
mouse thymocytes were replicated with other monoclonal anti-
bodies against the GR (Figure S2D). Imaging flow cytometry
found that GR was nuclear in mouse thymocytes that were incu-
bated in steroid-freemediumand treatedwith fix-only (Figure 4D,
top), consistent with previous exposure to glucocorticoids
in vivo. In contrast, nuclear GRwas lost after perm-fix (Figure 4D,
bottom), indicating that the GR became unliganded after incuba-
tion in steroid-freemedium. This interpretation was supported by
detection of nuclear GR in thymocytes incubated with cortico-
sterone prior to perm-fix (Figure 4D, bottom). GR staining inten-
sity increased as a function of corticosterone concentration, and
was bright in CD48 double-negative (DN) thymocytes and dim
in CD4+8+ double-positive (DP) thymocytes (Figure 4E), which
reflects the previously documented difference in GR expression
between these subsets (Brewer et al., 2002; Wiegers et al.,
2001). To confirm that the kinetics of ligand-dependent GR
detection after perm-fix were similar to those of chromatin inter-
actions, chromatin immunoprecipitation (ChIP) of GR was per-
formed on mouse thymocytes treated with corticosterone and
subsequently washed twice and incubated at room temperature
in steroid-free medium. GR association with the promoter of the
glucocorticoid-responsive gene Tsc22d3 (encoding the gluco-
corticoid-induced leucine zipper protein [Gilz]) was quantified
in ChIP and chromatin input samples by qPCR (Figure S2E),
and normalized to allow direct comparison with perm-fix results
(Figure 4F). The glucocorticoid-induced signal rapidly decayed
after glucocorticoid removal using either the perm-fix or ChIP
assay, with calculated half-lives of 13 and 14 min, respectively.
These were also similar to the half-life of GFP-GR in live or
perm-fixed 3617 cells (Figure 2F). This result demonstrates
that antibody staining of perm-fixed cells corresponds closely
with temporal dynamics of GR-chromatin association measured
by ChIP, rather than the dynamics of GR nuclear localization.
Permeabilization-Fixation Can Detect Differences in
Tissue Glucocorticoid Concentrations
To examine glucocorticoid signaling in non-circulating cells, thy-
mocytes and splenocytes from control mice or mice exposed to
45 min of handling stress were perm-fixed. Plasma corticoste-
rone was higher in stressed compared with unstressed mice,nd Exposure
, GFP-GR, or GFP-progesterone receptor bwere incubated with their cognate
d then kept on ice (Live), fixed, or perm-fixed. Cells were quantified by flow
e column. Data are representative of four independent experiments.
us steroid concentrations, perm-fixed, and measured by flow cytometry. Data
measured by flow cytometry. Data are representative of two independent
cocorticoid receptor; PR, progesterone receptor b; MFI, median fluorescence
Figure 4. Permeabilization-Fixation of Primary Cells Allows Antibody Detection of Chromatin-Associated GR
(A) Primary thymocytes frommicewith T lymphocyte-specific deletion of theGR (GRlck-Cre) or wild-type (WT)micewere treatedwith corticosterone, fixed or perm-
fixed, and stained for GR, and data were acquired by flow cytometry. Data are representative of two independent experiments.
(legend continued on next page)
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Figure 5. Chromatin-Associated GR Can Be Used to Detect Tissue and Cell-Specific Glucocorticoid Differences In Vivo
(A and B) Plasma and tissue samples were collected from (A) undisturbed or stressed (handling and movement) WT mice or (B) WT and Cyp11b1-deficient mice.
Total plasma corticosterone levels were quantified by immunoassay andmeans ±SD of duplicate measurements are shown in bar graphs. Cells were perm-fixed,
GR stained, and surface markers stained, and data were acquired by flow cytometry, shown in histograms. Data are representative of three independent
experiments. FMO, fluorescence minus one (no anti-GR antibody) control.and there was a corresponding increase in chromatin-associ-
ated GR staining across thymus and spleen lymphocyte sub-
sets (Figure S3; Figure 5A). Wild-type mice were also compared(B and C) Primary mouse thymocytes (B) or primary human peripheral blood m
surface stained, perm-fixed, andmeasured by flow cytometry. Estimated Kd value
for human T and B cells, respectively. Data are representative of two independe
(D) WT mouse thymocytes were treated with corticosterone, surface stained, and
are representative of two independent experiments. Scale bars, 10 mm.
(E) WT mouse thymocytes were treated with different corticosterone concentra
cytometry. Data are representative of two independent experiments. Scale bars,
(F) WT mouse thymocytes were incubated for 20 min in medium containing 107 M
the indicated times. One aliquot of cells was then fixed in 1% formaldehyde and C
to the Tsc22d3 (Gilz) gene promoter, and another aliquot was perm-fixed, GR stain
setting the corticosterone-treated (unwashed) sample equal to 100% induction
means ±SEM of three mice in two independent experiments.
See also Figure S2.
3636 Cell Reports 26, 3629–3642, March 26, 2019with Cyp11b1-deficient mice, which have greatly diminished
de novo glucocorticoid production (Mittelstadt et al., 2018).
Corticosterone was reduced in Cyp11b1/ compared withononuclear cells (C) were treated with various glucocorticoid concentrations,
s are 39 and 26 nM for mouse CD4+8+ and CD4+ thymocytes and 39 and 22 nM
nt experiments.
fixed or perm-fixed, and data were acquired by imaging flow cytometry. Data
tions, surface stained, perm-fixed, and data were acquired by imaging flow
10 mm.
corticosterone, then washed twice and incubated in steroid-free medium for
hIP-qPCR performed (as described in STARMethods) to quantitate GR binding
ed, and counted by flow cytometry. Data from both assays were normalized by
and the corticosterone-untreated sample set equal to 0% induction. Data are
Figure 6. Glucocorticoid Measurement by Ligand Titration Assay
(A) Protocol for estimation of corticosterone exposure. Cells were cultured in 0, 3, or 100 nM corticosterone (primary exposure), then divided into aliquots and
treated with various corticosterone concentrations (secondary exposure). Cells were then perm-fixed, and data were acquired by flow cytometry.
(B) GFP-GR 3617 cells treated as described above. Data are representative of two independent experiments.
(C) Blood samples were collected from mice immediately after disturbance (<2 min, n = 6) or after 15 min of handling stress (n = 5) and divided into aliquots.
Plasma was isolated, and total and free corticosterone were quantified by immunoassay (left two panels). Blood was incubated with the indicated corticosterone
concentrations, perm-fixed, and stained, and data were acquired by flow cytometry (secondary exposures, right panels). The corticosterone concentrations
shown in the rightmost panel were calculated using B cells as described in the STAR Methods. Data are presented as means ± SEM.
See also Figure S3.control mouse plasma, and there was a corresponding decrease
in chromatin-associated GR staining across thymocyte subsets
(Figure 5B, top). This decrease was not due to differential
expression of GR protein, because total GR staining was similar
in Cyp11b1/ and control mice (Figure 5B, bottom). These
results show that GR staining after perm-fix can identify endog-
enous differences in tissue corticosterone exposure.
A Ligand Titration Assay Quantitates Approximate
Glucocorticoid Concentrations in Cultured Cells and
Blood
Because there was a positive correlation between GR retention
andglucocorticoidconcentration,we reasoned that cells exposed
to a given corticosterone concentration would have a certainperm-fix GR signal, and that this signal would increase only if
they were subsequently exposed to a higher, but not lower, con-
centration of glucocorticoids in vitro. To test this, GFP-GR 3617
cells were cultured with known concentrations of corticosterone
for 30 min (primary exposure), after which aliquots were distrib-
uted into 96-well plates and increasing concentrations of cortico-
sterone were added (secondary exposure). After 5 min, the cells
were perm-fixed and GFP-GR retention quantitated by flow
cytometry (Figure 6A). The highest secondary steroid concentra-
tion at which the perm-fix GR signal did not increase should
approximate the concentration in the primary exposure. We
used a brief corticosterone treatment because the rapid loss of
GR-chromatin interaction after ligand removal is expected to
result in an underestimate of the actual primary glucocorticoidCell Reports 26, 3629–3642, March 26, 2019 3637
Figure 7. Targeted Delivery of TEC-Derived Glucocorticoids in the Thymus
(A) Thymi were collected from neonatal WT (n = 6) and Cyp11b1foxn1-Cre (n = 3) littermates; cells were perm-fixed, GR stained, and surface markers stained, and
data were acquired by flow cytometry. Specific MFI is the result of subtracting the non-specific staining of the same thymocyte subpopulation from GRlck-Cre
mice, which lack GR expression (WT or Cyp11b1foxn1-Cre MFI  GRlck-Cre MFI). Data are representative of three independent experiments. CD4trans, transitional
(CD4+CD8lo); DN, CD48; DP, CD4+8+; DPdull, CD4lo8lo; ISP, immature single positive (CD8+TCR).
(legend continued on next page)
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exposure. We found that an MFI (median fluorescence index)
increase of R3% followed by a sustained increase in MFI could
be used to identify the concentration of corticosterone in the pri-
mary culture. For example, when GFP-GR 3617 cells were
cultured in the absence of glucocorticoids, the highest corticoste-
rone concentration that did not result in an increased signal was
1 nM, indicating that 1 nM is the lower limit for the sensitivity of
the secondary exposure titration assay (Figure 6B, left). Similarly,
the signal in cells whose primary culture was in 3 nM corticoste-
rone deviated from the baseline at a secondary concentration of
8 nM (Figure 6B, center), and cells whose primary culture was
in 100 nM corticosterone showed no consistent increase at any
secondary corticosterone concentration, demonstrating that the
plateau had been reached (R100 nM) (Figure 6B, right). Flow
cytometry-detected chromatin-associated GR may therefore be
used to quantitatively estimate glucocorticoid exposure at the
individual cell level within the physiologic range of 1–100 nM.
To determine whether perm-fix GR retention can be used to
estimate exposure of primary cells to glucocorticoids in vivo,
circulating blood was obtained from mice within 2 min of initial
disturbance (baseline) or after 15 min of handling stress. Hepa-
rinized blood was aliquoted into different concentrations of corti-
costerone, incubated for 7.5–10 min at room temperature, and
perm-fixed. As expected, exposure to a stressor increased total
plasma corticosterone (from 40 to 540 nM; Figure 6C).
Because the majority of plasma corticosterone is buffered by
carrier proteins, we measured the free and therefore biologically
active fraction, which after handling stress increased from 3 to
75 nM (Figure 6C). Using secondary ligand exposure and
perm-fix, we found corresponding differences in GR staining
patterns in circulating lymphocytes (Figure 6C, center). Under
non-stress conditions, the estimated endogenous corticoste-
rone exposure was calculated to be 9 nM, and after stress was
75 nM (Figure 6C, right). These results show that perm-fix GR
staining can quantitatively identify differences in corticosterone
exposure in vivo, which correspond closely with the bioavailable
glucocorticoid.
Identification and Approximate Quantitation of Cell-
Targeted Delivery of Paracrine Glucocorticoids in the
Thymus
Because thymocytes undergoing antigen-specific selection are
affected by locally synthesized glucocorticoids (Mittelstadt
et al., 2018), we asked whether differences in chromatin-asso-
ciated GR could identify individual thymocytes being acted
upon by paracrine-supplied glucocorticoids. We collected and
immediately perm-fixed and then stained GR in thymocytes
of post-natal day 1 control and Cyp11b1foxn1-Cre mice. TECs(B) Thymi were collected from WT (n = 3) and Cyp11b1foxn1-Cre (n = 3) imm
permeabilized, intracellular proteins stained, washed, and data acquired by flow c
multiple comparisons. DP, CD4+8+; DPdull, CD4lo8lo.
(C) Thymus and spleen were collected from mice (n = 6) immediately after distu
corticosterone concentrations for 7.5 min, perm-fixed, stained, and data acquired
were calculated as described in STAR Methods, and subsets were compared us
DP, CD4+8+; DPdull, CD4lo8lo.
All bar graphs show means ± SEM with significance indicated by *p < 0.05, **p <
See also Figure S3.of Cyp11b1foxn1-Cre mice are unable to synthesize glucocorti-
coids, and antigen-induced apoptosis is increased in devel-
oping thymocytes (Mittelstadt et al., 2018). In the majority of
thymocyte subsets, chromatin-associated GR levels were iden-
tical between control and Cyp11b1foxn1-Cre mice, indicating
similar exposure to glucocorticoids in vivo (Figure 7A). However,
in CD4+8+TCRhi thymocytes, which have been activated by TCR
signaling (Kearse et al., 1995),Cyp11b1foxn1-Cremice had a clear
reduction in chromatin-associated GR. These data suggest that
TCR-signaled CD4+8+ thymocytes, which represent the small
fraction of total CD4+8+ cells that recognize self-antigens
(5%), are acted on by TEC-synthesized glucocorticoids
in situ. This cell specificity, moreover, demonstrates that TEC-
derived glucocorticoids mediate their effect upon specific cells,
rather than bathing the whole organ in uniformly elevated
glucocorticoid levels. Because glucocorticoids antagonize
thymocyte negative selection, the effect of TEC-derived gluco-
corticoids on key indicators of negative selection, PD-1 and Bim
(Baldwin and Hogquist, 2007; Blank et al., 2003; Gray et al.,
2012), was examined. The frequency of PD-1+Bim+ cells was
similar between the majority of wild-type and Cyp11b1foxn1-Cre
thymocytes, but was elevated 50% in CD4+8+TCRhi thymo-
cytes in Cyp11b1foxn1-Cre mice (Figure 7B), confirming that
TEC-derived glucocorticoids act specifically on CD4+8+TCRhi
thymocytes, and that in their absence negative selection is
enhanced in these cells. A ligand titration assay was performed
to quantify exposure of thymocyte subpopulations to glucocor-
ticoids. In these experiments we used thymocytes from mice in
which the GR has been replaced by a GFP-GR fusion protein
that is functionally indistinguishable from the endogenous
GR (Brewer et al., 2002) (Figure S3), allowing us to directly mea-
sure GR levels. Thymocytes were aliquoted into wells whose
medium contained the indicated corticosterone concentrations,
incubated for 7.5 min at room temperature, and perm-fixed.
CD4+8+TCRlo (unselected) thymocytes were found to have
been exposed to a glucocorticoid concentration of6 nM in vivo
(Figure 7C). In contrast, the CD4+8+TCRhi (responding to self;
Kearse et al., 1995) were exposed to a 3-fold higher concentra-
tion (18 nM). Although not statistically significant, glucocorti-
coid levels perceived by CD4lo8lo thymocytes, which are
enriched for cells that have been triggered via the TCR and
are progressing to apoptosis, were slightly elevated compared
with CD4+8+TCRlo cells. CD4+8 and CD48+ single positive,
as well as mature splenic T and B cells, had glucocorticoid
exposures similar to CD4+8+TCRlo cells. These data confirm
specific targeting of paracrine glucocorticoids to CD4+8+TCRhi
thymocytes and, more broadly, quantitative cell-specific het-
erogeneity in paracrine glucocorticoid signaling within an organ.ediately after disturbance, cells dispersed, surface markers stained, fixed,
ytometry. Subsetswere compared using a two-way ANOVA andSidak’s test for
rbance, cells dispersed, and aliquots immediately incubated with a range of
by flow cytometry. The corticosterone concentrations shown in the bar graph
ing a Kruskal-Wallis test and Dunn’s test for multiple comparisons.
0.01, and ***p < 0.001.
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DISCUSSION
Activation of steroid receptors by their cognate ligands is impor-
tant in myriad cellular processes, but detection, quantification,
and even identification of these ligands and their cellular targets
are major obstacles to investigating steroid function. Current
methods are unable to quantitate ligand concentrations in situ
with single-cell resolution, especially in situations where produc-
tionmay occur in a paracrine or autocrinemanner. Ligand access
to and activation of steroid receptors is even less clear. The tech-
nique outlined in this report has several distinct advantages over
existing approaches. First, rather than detecting combined intra-
cellular and extracellular ligands that may ormay not be available
to the receptor, it uses the receptor itself as a biosensor. Thus,
factors that influence the effective ligand concentration, such
as carrier proteins that act as buffers, the capacity to diffuse
through membranes, and intracellular steroid metabolism, are
accounted for, as shown by a tight correlation between the sec-
ondary exposure titration assay and free glucocorticoid levels in
the plasma. Second, perm-fix primarily detects the liganded,
chromatin-associated receptor fraction. Whereas nuclear shut-
tling of liganded cytosol-resident receptors (Giuliano et al.,
1997) and expression of receptor target genes (Mittelstadt
et al., 2018) have been used as indicators of steroid signaling,
receptor export from the nucleus and mRNA degradation
after ligand removal both take many hours (Liu and DeFranco,
2000; Yang et al., 2003). In contrast, perm-fix detection of the
liganded receptor fraction, which was lost within minutes of
ligand removal, results in high temporal resolution of receptor ac-
tivity detection. GR retention in 3617 cells after perm-fix (9%–
18% without and 39%–48% with glucocorticoid; see Figures 1
and 3) also roughly approximated the proportion of chromatin-
bound GR as measured by single-molecule tracking in live
3617 cells (13%without and44%with glucocorticoid) (Paaki-
naho et al., 2017). Third, the perm-fix method allows discrimina-
tion of effective ligand concentrations at the single-cell level.
Fourth, because the perm-fix approach measures the conse-
quences of receptor occupancy and not the ligand itself, it is
ligand agnostic. Thus, wheremultiple hormone variants are avail-
able (as in the thymus; Taves et al., 2015, 2016a), perm-fix effec-
tively measures the active concentration of the aggregate, which
is ultimately what is biologically relevant. This implies that perm-
fix could be used to detect the activity of nuclear receptors for
which an endogenous ligand has not yet been identified. Finally,
the perm-fix assay is simple, inexpensive, and rapid. It may be
combined with other methods, such as fluorescence-activated
cell sorting and ChIP, to study endogenous receptor promoter
occupancy in different cell subsets from the same tissue sample.
The thymus is an organ in which paracrine production of gluco-
corticoids plays an important role in the generation of T cells
essential for adaptive immunity. TCR occupancy on immature
thymocytes leads to a continuum of responses depending
upon affinity for the ligand, from death by neglect (low affinity)
to survival (positive selection, moderate affinity) to activation-
induced death (negative selection, high affinity). Glucocorticoids
produced by a small number of TECs regulate this process by
dampening TCR signals and promoting positive selection. This
is demonstrated by two different genetic models, thymocyte3640 Cell Reports 26, 3629–3642, March 26, 2019GR deficiency or TEC Cyp11b1 deficiency. In both, reduced
glucocorticoid signaling increases TCR-dependent apoptosis
(negative selection) leading to an altered and ineffective TCR
repertoire (Mittelstadt et al., 2012, 2018). Although the require-
ment of glucocorticoids is clear, it has been thus far impossible
to determine which cells are signaled by glucocorticoids, and
thus how negative selection is antagonized. By using GR-
chromatin binding as a biosensor, we have been able to show
that glucocorticoid signaling occurs at a specific stage in thymo-
cyte differentiation: CD4+8+ cells that have been stimulated
by self-antigen as assessed by TCR upregulation. These obser-
vations address at least two long-standing questions about
local glucocorticoid production. First, paracrine hormone deliv-
ery was highly targeted. The vast majority of thymocytes were
exposed to the same low level of free corticosterone (6 nM),
with only CD4+8+TCRhi cells exposed to a higher concentration
(18 nM). This is consistent with the finding that in the absence
of TEC glucocorticoid production, GR retention after perm-fix
analysis was reduced specifically in this subset. Importantly, in
this context in which glucocorticoids are supplied only by the
circulation, these self-antigen-stimulated polyclonal thymocytes
exhibited higher levels of markers indicating impending cell
death, consistent with previous observations made in mice in
which all thymocytes expressed the same positively selected
transgenic TCR (Mittelstadt et al., 2018). Therefore, rather than
being distributed throughout the organ, locally synthesized glu-
cocorticoids were delivered directly to their biologically relevant
targets. Because antigen presentation by TECs is the driver of
positive selection, this direct delivery likely occurs because of
physical proximity between the glucocorticoid-producing cell
and the recipient cell. Delivery of lipophilic steroids across closely
apposed membranes might be especially efficient, bypassing
CBG and albumin in the interstitial fluid. Second, we conclude
that a 3-fold elevation in ambient glucocorticoid levels is suffi-
cient to skew antigen-induced negative selection toward positive
selection for thymocytes bearing TCR with the appropriate affin-
ity for self-antigen. This is particularly interesting because we
previously found that a 50% decrease in thymocyte GR expres-
sion was sufficient to skew positive toward negative selection
(Mittelstadt et al., 2012). It seems likely therefore that the biolog-
ically effective window for glucocorticoid-regulated thymocyte
selection spans a 2- to 3-fold range of responsiveness.
We believe that the perm-fix technique developed here can
be broadly applicable for the interrogation of paracrine and
autocrine hormone signaling and more generally, transcription
factor-chromatin interactions. In particular, the retention of
histone H3 protein after perm-fix indicates that chromatin-
cross-linking should be broadly useful for investigation of
transcription factor activity. However, because the removal of
ligand can result in rapid reversal of chromatin binding, detection
of paracrine or autocrine signaling in vivo requires rapid cell
collection. Thus, it is well suited for work with hematopoietic cells
that can be easily dispersed from tissues. In situations where
disruption of cell-cell interactions is more difficult, for example,
in neural tissue, it might be useful to adapt this method by tissue
perfusion with a perm-fix agent. This would have the added
benefit of leaving organs intact, allowing visualization of cells in
their normal anatomical context by microscopy. Alternatively,
perm-fix treatment could be performed on cultured tissue
sections, or other assays that specifically measure receptor-
chromatin association (such as proximity ligation assay) might
be usedwithout the need for permeabilization. Such an approach
might be used with fixed tissue biopsies from patients.
We have used the perm-fix approach to show cell-targeted
delivery of paracrine glucocorticoids and to quantify intra-organ
heterogeneity in active glucocorticoid concentrations. We hy-
pothesize that this approach might be used to reveal similar
‘‘cytokine-like’’ behavior of steroids and other lipid molecules
in multiple other organs and contexts. Basal and inducible
expression of steroid metabolic enzymes suggests that targeted
glucocorticoid signaling may occur in other lymphoid organs
(Taves et al., 2015, 2016b) and barrier sites (Cima et al., 2004;
Noti et al., 2010; Slominski et al., 2005), and the identification
of glucocorticoid target cells in these tissues is important to un-
derstand homeostatic regulation of immunity and inflammation.
Furthermore, as targeted glucocorticoid therapies begin to enter
clinical use (Buttgereit et al., 2005), identification of optimal
glucocorticoid target cells may greatly improve the efficacy
and risk profiles of glucocorticoid treatments.
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Thévenot, D.R., Toth, K., Durst, R.A., andWilson, G.S. (2001). Electrochemical
biosensors: recommended definitions and classification. Biosens. Bio-
electron. 16, 121–131.
Tobiansky, D.J., Korol, A.M., Ma, C., Hamden, J.E., Jalabert, C., Tomm, R.J.,
and Soma, K.K. (2018). Testosterone and corticosterone in the mesocortico-
limbic system of male rats: effects of gonadectomy and caloric restriction.
Endocrinology 159, 450–464.
Vacchio, M.S., Papadopoulos, V., and Ashwell, J.D. (1994). Steroid production
in the thymus: implications for thymocyte selection. J. Exp. Med. 179, 1835–
1846.
Van Engelenburg, S.B., and Palmer, A.E. (2008). Fluorescent biosensors of
protein function. Curr. Opin. Chem. Biol. 12, 60–65.
Wang, Y., Botvinick, E.L., Zhao, Y., Berns, M.W., Usami, S., Tsien, R.Y., and
Chien, S. (2005). Visualizing the mechanical activation of Src. Nature 434,
1040–1045.
Wasner, G., Hennermann, I., and Kratochwil, K. (1983). Ontogeny of mesen-
chymal androgen receptors in the embryonic mouse mammary gland. Endo-
crinology 113, 1771–1780.
Weikum, E.R., Knuesel, M.T., Ortlund, E.A., and Yamamoto, K.R. (2017).
Glucocorticoid receptor control of transcription: precision and plasticity via
allostery. Nat. Rev. Mol. Cell Biol. 18, 159–174.
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Anti-mouse B220 (clone RA3-6B2) BD PharMingen Cat# 553090
Anti-mouse Bim (clone C34C5) Cell Signaling Technology Cat# 2933; RRID: AB_1030947
Anti-mouse CD4 (clone RM4-5) eBioscience Cat# 47-0042-82; RRID: AB_1272183
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Anti-mouse CD69 (clone H1.2F3) eBioscience Cat# 25-0691-82; RRID: AB_469637
Anti-mouse Histone H3 (clone D2B12) Cell Signaling Technology Cat# 4620; RRID: AB_1904005
Anti-mouse PD-1 (clone J43) eBioscience Cat# 12-9985-82; RRID: AB_466295
Anti-mouse TCRb (clone H57-597) BD PharMingen Cat# 560657; RRID: AB_1727575
Anti-mouse Ter119 (clone Ter-119) Biolegend Cat# 116207; RRID: AB_313708
Anti-human CD3 (clone HIT3a) eBioscience Cat# 12-0039-42; RRID: AB_10853029
Anti-human CD19 (clone HIB19) eBioscience Cat# 56-0199-42; RRID: AB_2043819
Anti-b-actin (clone AC-15) Sigma Cat# A5441; RRID: AB_476744
Anti-GR (clone G-5) Santa Cruz Cat# sc-393232; RRID: AB_2687823
Anti-GR (clone D8H2) Cell Signaling Technology Cat# 12007; RRID: AB_11179215
Anti-GR (clone BuGR2) Novus Cat# NB300-731; RRID: AB_608643
Anti-GR (clone 5E4) US Biological Cat# G3030-01M
Chemicals, Peptides, and Recombinant Proteins
16% Formaldehyde solution Thermo Cat# 28908
Corticosterone Sigma Cat# 27840
Cortisol Sigma Cat# H-4001
Cytofix/Cytoperm fixation/permeabilization kit BD Biosciences Cat# 554722
Dehydrocorticosterone Steraloids Cat# Q3690-000
Deoxycorticosterone Sigma Cat# D6875
Dexamethasone Sigma Cat# D1756
Formaldehyde solution Sigma Cat# 252549-25ML
PowerUp SYBR Green Master Mix Applied Biosystems Cat# A25742
Progesterone Sigma Cat# P-0130
Testosterone Nutritional Biochemicals Cat# 103010
Transcription factor staining buffer set eBioscience Cat# 00-5523-00
Triton X-100 solution Fluka Cat# 93443
Critical Commercial Assays
Corticosterone Chemiluminescent Immunoassay Arbor Assays Cat# K014
SimpleChIP Enzymatic Chromatin IP Kit Cell Signaling Technology Cat# 9003S
SuperSignal West Dura Substrate Thermo Cat# 34075
Experimental Models: Cell Lines
Mouse: 3617 GFP-AR cells Presman et al., 2016 N/A
Mouse: 3617 GFP-GRwt cells Presman et al., 2016 N/A
Mouse: 3617 GFP-GRmon cells Presman et al., 2016 N/A
Mouse: 3617 GR/ cells Presman et al., 2016 N/A
Mouse: 3617 GFP-PR cells Presman et al., 2016 N/A
(Continued on next page)
Cell Reports 26, 3629–3642.e1–e4, March 26, 2019 e1
Continued
REAGENT or RESOURCE SOURCE IDENTIFIER
Mouse: 3617 mCherry-ER cells Presman et al., 2016 N/A
Human: HEK293T cells ATCC CRL-3216; RRID: CVCL_0063
Experimental Models: Organisms/Strains
C57BL/6J mice The Jackson Laboratory Jax: 000664; RRID: IMSR_JAX:000664
Cyp11b1actin-Cre mice Mittelstadt et al., 2018 N/A
Cyp11b1foxn1-Cre mice Mittelstadt et al., 2018 N/A
GFP-GR mice Brewer et al., 2002 N/A
GRlck-Cre mice Mittelstadt et al., 2012 Jax: 021021; RRID: IMSR_JAX:021021
Oligonucleotides
Primer: Tsc22d3 forward: TGGTGCCAAATGTCAAGAAG This paper N/A
Primer: Tsc22d3 reverse: TATGTTTGCCTGAGCCCTCT This paper N/A
Recombinant DNA
Plasmid: GFP-GRwt Paakinaho et al., 2017 N/A
Plasmid: GFP-GRmon Paakinaho et al., 2017 N/A
Plasmid: GFP-GRC440G Paakinaho et al., 2017 N/A





Image Lab Bio-Rad http://www.bio-rad.com/
Prism GraphPad Software https://www.graphpad.com/CONTACT FOR REAGENT AND RESOURCE SHARING
Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Jonathan
D. Ashwell (jda@pop.nci.nih.gov).
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Cell Culture
3617 cells were cultured in DMEM (GIBCO) supplemented with 10% heat-inactivated FBS, 2 mM L-glutamine, 50 mM 2-mercaptoe-
thanol, 100 mg/ml gentamicin, and 5 mg/ml tetracycline. The 3617 cell line is derived from the 3134mousemammary adenocarcinoma
line. 3617 cells stably expressed a GFP-tagged wild-type mouse GR (GFP-GR) or a dimerization-impaired GR mutant containing
the A465T/I634A amino acid substitutions (GFP-GRmon) under the control of a tetracycline-repressible promoter, or were GR-
deficient (KO). Additional 3617 lines stably expressed a GPF-tagged androgen receptor (GFP-AR), an mCherry-tagged estrogen
receptor a (mCh-ER), or GFP-tagged progesterone receptor b (GFP-PR) under the control of a tetracycline-repressible promoter.
All 3617 lines and mutant receptors have been previously described (Presman et al., 2016). Prior to experiments, 3617 cells were
cultured overnight in DMEM supplemented with 10% charcoal-stripped heat-inactivated FBS, L-glutamine, 2-mercaptoethanol,
and gentamicin (as above) but no tetracycline. Primary mouse cells and PBMCs were cultured in RPMI 1640 (GIBCO) supplemented
with 10% FBS, 2 mM L-glutamine, 50 mM 2-mercaptoethanol, and 100 mg/ml gentamicin. Prior to experiments, cells were cultured
for at least one hour in RPMI 1640 containing 10% charcoal-stripped heat-inactivated FBS, L-glutamine, 2-mercaptoethanol, and
gentamicin (as above).
Mice
Wild-type C57BL/6 mice were obtained from Jackson Laboratories. Mice with Lck promoter-driven T cell GR deletion (GRlck-Cre)
(Mittelstadt et al., 2012), Actb promoter-driven global Cyp11b1 deletion (Cyp11b1/) (Mittelstadt et al., 2018), or Foxn1
promoter-driven TEC Cyp11b1 deletion (Cyp11b1foxn1-Cre) (Mittelstadt et al., 2018) were generated by us and have been described
previously. GFP-GR knockin mice were the kind gift of Dr. Louis J. Muglia (Brewer et al., 2002). Mice were between five and eight
weeks of age unless otherwise specified. We were unable to detect any sex differences and therefore pooled female and male
mice for all analyses. Mice were kept on a 12:12 light:dark cycle, with ad lib access to standard chow (NIH-31, Teklad). To stimulate
an endogenous corticosterone response, mice were held by the scruff of the neck for approximately 15 s, transfered to a new, lidlesse2 Cell Reports 26, 3629–3642.e1–e4, March 26, 2019
cage and left on the benchtop for 10 min, and again helf by the scruff of the neck for 15 s. These ‘‘stress’’ exposed mice were
euthanized 15 min after initial disturbance of the home cage. For experiments examining endogenous glucocorticoids (basal or
stress-induced) mice were collected between 10 am and 3 pm (Zeitgeiber time 4 to 9). All protocols and procedures were approved
by the NCI Animal Care and Use Committee and followed the NIH Guide for the Care and Use of Laboratory Animals guidelines.
METHOD DETAILS
Flow Cytometry
For experiments using 3617 or HEK293 cells, approximately 106 cells were aliquoted into a V-bottom 96-well plate, centrifuged, the
supernatant decanted, and the cells resuspended in 100 mL of ice-cold fixative. For determination of chromatin-associated protein by
permeabilization-fixation, samples were fixed with FoxP3 transcription factor fixation buffer (eBioscience) or FACS buffer (PBS
containing 2% charcoal-stripped FBS, 0.5% bovine serum albumin, and 0.05% sodium azide) with 2% formaldehyde (Sigma,
252549) and 0.5% Triton X-100 (Fluka) for 20 min at room temperature. For determination of total intracellular protein by fixation
alone, samples were fixed with Cytofix/Cytoperm (BD Biosciences) or FACS buffer containing 2% formaldehyde for 20 min at
room temperature. Samples were then diluted and washed with ice-cold permeabilization buffer (eBioscience) or FACS buffer
containing 0.1% Triton X-100, and in some cases incubated with intracellular staining antibodies (1:100) on ice for 30 min and
then washed twice with the same buffer. Cells were then resuspended in FACS buffer and data were obtained using LSR Fortessa
SORP and FACS Canto II flow cytometers with FACSDiva software (BD Biosciences) and analyzed with FlowJo software (TreeStar).
Median fluorescence intensity (MFI) was used for all analyses.We occasionally comparedmedian andmean fluorescence intensities,
and results were nearly identical. For experiments using fresh primary cells, tissues were dispersed in PBS containing 2% charcoal-
stripped FBS, and approximately 53 106 cells were aliquoted into tubes and resuspended in 125 mL of ice-cold perm-fix or total fix,
incubated for 20 min at room temperature, and washed with permeabilization buffer as above. Unless otherwise specified, intracel-
lular GR staining was done overnight at 4 (antibodies diluted 1:100) with an Alexa 488 or Alexa-647 conjugated mouse monoclonal
antibodie (G-5, Santa Cruz). Cells were thenwashed twice and resuspended in FACSbuffer. Surfacemarkers were stained for at least
30 min on ice (antibodies diluted 1:200 - 1:300), cells washed, and data obtained and analyzed as described above. For ligand titra-
tion analysis to estimate endogenous glucocorticoid exposure, cells were quickly dissociated and diluted in 50 ml of PBS containing
2% FBS with various corticosterone concentrations. After a brief incubation at room temperature, cells were diluted with 250 ul of
ice-cold perm-fix buffer, incubated 20 min at room temperature, and washed and stained as described above. For imaging flow
cytometry, 2 mM DAPI was added to fixed and fix-perm treated cells, data were obtained using an ImageStream Mark II flow
cytometer (Amnis), and analysis performed using IDEAS software (Amnis). Analyses were performed on all collected data, and
representative images were selected from cells gated to include approximately 5% of cells spanning the GR MFI value or median
nuclear translocation score for a given cell population. Relative nuclear translocation was quantified using the Similarity Score in
IDEAS, using the formula S = ln [ (1+r) / (1-r) ], where S is the similarity score and r is the Pearson correlation coefficient comparing
GFP pixel intensities between GFP and DAPI images of the same cell. For measurement of lymphocyte GR-chromatin association
in situ, thymi were dispersed in FACS buffer and immediately perm-fixed for 25 min at room temperature. Cells were then washed
with permeabilization buffer, stained for intracellular and surface proteins, and data acquired on a flow cytometer. Gating strategies
used to analyze blood, spleen, and thymus cells are demonstrated in (Figure S3).
Western Blot
Cell samples were boiled in SDS sample buffer for 10 min, proteins separated by SDS-PAGE, transferred (Trans-Blot Turbo, Bio-
Rad), blots blocked with 5% dried milk (Bio-Rad), incubated overnight with primary antibodies against GR (G-5), b-actin (AC-15),
or Histone H3 (D2B12) and detected with HRP-conjugated secondary antibodies and enhanced chemiluminescence substrate
(SuperSignal West Dura, Thermo) using a ChemiDoc imaging system (Bio-Rad).
ChIP
ChIP was performed using SimpleChIP kit reagents (Cell Signaling, 9003) according to the manufacturer’s protocol. 153 106 mouse
thymocytes were treated with 106 M corticosterone, cross-linked for 10 min with 1% methanol-free formaldehyde at room
temperature on a rocker, and quenched with glycine for 5 min. Cells were washed twice with ice-cold PBS containing complete pro-
tease inhibitor cocktail (Roche, Complete), resuspended in cell lysis buffer (kit Buffer A), and incubated 10 min on ice with regular
mixing. Nuclei were pelleted and washed in nuclei lysis buffer (kit Buffer B), chromatin resuspended in nuclei lysis buffer and digested
with 1000 gel units of micrococcal nuclease at 37 with periodic mixing by inversion. Digestion was stopped by adding EDTA to
50 mM and chilling in ice. Pelleted nuclei were resuspended in ChIP buffer (kit reagent), incubated 10 min on ice, sonicated in a
QSonica Q800R2 (10 s on, 25% amplitude), and chromatin aliquoted to different tubes (input controls and ChIP samples). Samples
(53 106 cells per reaction) were brought to 500 mL with ChIP buffer, rotated overnight at 4 with a rabbit anti-mouse GR monoclonal
antibody (D8H2, Cell Signaling), rotated for 2 h with 30 mL of Protein G magnetic beads (kit reagent), washed three times with ChIP
buffer, and washed once with high salt buffer. Samples were then incubated in 150 mL ChIP elution buffer (kit) for 30 min at 65 at
1200 rpm, supernatant cross-links reversed for 2 h at 65 with 200 mM NaCl and 2 mL Proteinase K (20 mg/ml), and DNA purified
with QIAquick PCR purification columns (QIAGEN). Quantitative PCR for the Tsc22d3 gene (encoding the glucocorticoid-inducedCell Reports 26, 3629–3642.e1–e4, March 26, 2019 e3
GILZ protein) promoter was performed on a QuantStudio 6 system (Applied Biosystems) using PowerUp SYBR Green Master
Mix (Applied Biosystems) with forward primer 50-TGGTGCCAAATGTCAAGAAG-30 and reverse primer 50-TATGTTTGCCTGAG
CCCTCT-30.
Reagents
Corticosterone (Sigma), cortisol (Sigma), 17b-estradiol (Sigma), progesterone (Sigma), and testosterone (Nutritional Biochemicals)
were kept as 102 M stocks in ethanol at 20C and diluted immediately before being used in experiments.
QUANTIFICATION AND STATISTICAL ANALYSIS
Glucocorticoid Quantification
Plasma corticosterone was measured using a commercial chemiluminescent immunoassay kit (Arbor Assays, K014). For total
corticosterone, 5 mL of plasma was incubated with 5 mL of dissociation reagent, diluted with 490 mL assay buffer, and assayed in
duplicate according to the manufacturer’s instructions. For free corticosterone, plasma samples were loaded into Microcon Ultracel
YM-10 filters (Millipore, 42406), centrifuged 10,000 3 g for 30 min at room temperature, and corticosterone was measured in the
filtrate (free corticosterone), retentate (bound corticosterone), and in unfiltered plasma (total corticosterone). Quantification of cellular
corticosterone exposure was performed using a secondary exposure ligand titration assay. Cell aliquots were treated with increasing
amounts of corticosterone and GR retention was quantified by flow cytometry. An MFI increase ofR 3% from the previous concen-
tration followed by further sustained increases in MFI was used to identify the first concentration greater than the primary exposure,
and the concentration preceding thisR 3% increase was considered to be the corticosterone concentration in the primary exposure.
Statistical Analysis
Analyses were performed using GraphPad Prism software. KD and Bmax values were calculated using the saturation one-site total
binding function, and using the saturation – one-site specific binding on specific binding data gave nearly identical results. GR-
chromatin half-life values were calculated using the dissociation – one phase exponential decay function. Thymocyte and splenocyte
glucocorticoid concentrations were compared using a Kruskal-Wallis test followed by Dunn’s test for multiple comparisons. Error
bars indicate SEM unless otherwise stated and significance was set at p < 0.05. All experiments were performed at least twice,
and replicates and sample numbers are indicated in the figure captions.e4 Cell Reports 26, 3629–3642.e1–e4, March 26, 2019
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Supplementary Figure 1. Simultaneous permeabilization and fixation (perm-fix) retains liganded 
glucocorticoid receptor.
(a) 3617 cells expressing a GFP-glucocorticoid receptor (GFP-GR) fusion protein were cultured in steroid-free 
medium, incubated for 60 min with or without 10-6 M corticosterone (Cort), and trypsinized. Cells were then kept 
on ice (Live), briefly washed in permeabilization buffer (eBioscience) and fixed with the eBioscience transcription 
factor fixation reagent (Wash → perm-fix), or fixed and washed in permeabilization buffer (Perm-fix → wash). 
GFP-GR median fluorescence index (MFI) values in insets. Data were acquired by flow cytometry.
(b) Relative change in GFP-GR MFI values after corticosterone treatment, for (a).
(c) Relative change in 3617 cell GFP-GR MFI values after corticosterone treatment, simultaneous perm-fix with 
the indicated permeabilization buffer and methanol-free or methanol-containing formaldehyde, and acquisition by 
flow cytometry.
(d) GFP-GR expressing 3617 cells were incubated in the absence or presence of corticosterone for 15 min, then 
kept on ice (“Live”), fixed with BD Cytofix/Cytoperm, or fixed with eBioscience FoxP3 transcription factor 
fixative reagent. Cell were washed and GFP-GR quantified by flow cytometry.
(e) 3617 cells expressing a GFP-androgen receptor (GFP-AR), mCherry-estrogen receptor (mCh-ER), GFP-GR, or 
GFP-progesterone receptor β (GFP-PR) fusion proteins were cultured in steroid-free medium, incubated for 20 min 
with or without 10-6 M steroid (testosterone, 17β-estradiol, corticosterone, or progesterone, respectively), then kep 
on ice (“Live”), fixed, or perm-fixed. Cell were quantified by flow cytometry. Data are presented as the relative 
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Figure S1. Simultaneous permeabilization and fixation (perm-fix) retains liganded glucocorticoid receptor. 
Related to Figure 1 and 3. 
(A) 3617 cells expressing a GFP-glucoc rticoid receptor (GFP-GR) fusion protein were cult red in steroid-free 
medium, incubated for 60 min with or without 10-6 M corticosterone (Cort), and trypsinized. Cells were then kept on 
ice (Live), briefly washed in p rmeabilization buffer (eBioscience) a d fixe  with the eBioscience transcription factor 
fixation reagent (Wash → perm-fix), or fixed and washed in permeabilization buffer (Perm-fix → wash). GFP-GR 
median fluorescence index (MFI) values in insets. Data were acquired by flow cytometry. 
(B) Relative change in GFP-GR MFI values after corticosterone treatment, for (a). 
(C) Relative change in 3617 cell GFP-GR MFI values after corticosterone treatment, simultaneous perm-fix with the 
indicated permeabilization buffer and methanol-free or methanol-containing formaldehyde, and acquisition by flow 
cytometry. 
(D) GFP-GR expressing 3617 cells were incubated in the absence or presence of corticosterone for 15 min, then kept 
on ice (“Live”), fixed with BD Cytofix/Cytoperm, or fixed with eBioscience FoxP3 transcription factor fixative 
reagent. Cell were washed and GFP-GR quantified by flow cytometry. 
(E) 3617 cells expressing a GFP-androgen receptor (GFP-AR), mCherry-estrogen receptor (mCh-ER), GFP-GR, or 
GFP-progesterone receptor β (GFP-PR) fusion proteins were cultured in steroid-free medium, incubated for 20 min 
with or without 10-6 M steroid (testosterone, 17β-estradiol, corticosterone, or progesterone, respectively), then kep on 
ice (“Live”), fixed, or perm-fixed. Cell were quantified by flow cytometry. Data are presented as the relative increase 


















Supplementary Figure 2. Antibody GR staining and permeabilization-fixation conditions in mouse thymocytes.
(a) 3617 cells expressing the wild-type GR (GFP-GRwt), dimerization-impaired GR (GFP-GRmon), or deficient for GR 
(KO) were treated with different concentrations of corticosterone, perm-fixed, stained with anti-GR antibody (clone G-5) 
and a secondary Alexa 647-conjugated anti-mouse antibody, and data acquired by flow cytometry. Live cell GFP-GR MFI 
values are shown in Fig. 2c).
(b) WT and GRlck-Cre mouse thymocytes were surface stained, fixed, and stained for GR using the specified monoclonal 
antibodies. The 5E4 antibody was directly conjugated to FITC, while BuGR2 and G-5 were detected with a secondary 
Alexa 594-conjugated anti-mouse antibody. CD4+8+ DP thymocytes are shown.
(c) WT mouse thymocytes were incubated with or without 10-6 M corticosterone, perm-fixed with the indicated 
combination of permeabilization buffer and formaldehyde, and stained for GR using an Alexa 488-conjugated G-5 
monoclonal antibody. The relative increase in MFI after corticosterone treatment is shown.
(d) WT mouse thymocytes were incubated in medium containing the specified amount of corticosterone, surface markers 
were stained, cells perm-fixed, and GR stained with D8H2-Alexa 488 or 5E4-FITC monoclonal antibodies (G-5-Alexa 
488 shown in Fig. 4b).
(e) WT mouse thymocytes were incubated for 20 min in medium containing 10-7 M corticosterone, washed twice and 
incubated in steroid-free medium, and collected at the indicated times. One aliquot was fixed in 1% formaldehyde and 
ChIP-qPCR performed to quantitate GR binding to the Tsc22d3 (Gilz) gene promoter. Another aliquot was perm-fixed, 





























































































































































Figure S2. Antibody GR stai ing and permeabilization-fixation conditions in mouse thymocytes. Related to Figure 
4. 
(A) 3617 cells exp essing the wild-type GR (GFP-GRwt), dimerization-impaired GR (GFP-GRmon), or deficient for 
GR (KO) were treated with different concentrations of corticosterone, perm-fixed, stained with anti-GR antibody 
(clone G-5) and a secondary Alexa 647-conjugated anti-mouse antibody, and data acquired by flow cytometry. Live 
cell GFP-GR MFI values are shown in Fig. 2c). 
(B) WT and GRlck-Cre mouse thymocytes were surface stained, fixed, and stai d fo  GR using e specified 
monoclonal antibodies. The 5E4 antibody was directly conjugated to FITC, wh le BuGR2 nd G-5 were detected 
with a secondary Alexa 594-conjugat d anti-mouse antibody. CD4+8+ DP thymocytes are shown. 
(C) WT mouse thymocytes w re incubated with or without 10-6 M corticosterone, perm-fixed with th  indicated 
combination of permeabilization buffer d formaldehyde, and stained for GR using an Alexa 488-conjugated G-5 
monoclonal antibody. The relative increase in MFI after corticosterone treatment is shown. 
(D) WT mouse thymocytes were incubated in medium containing the specified amount of corticosterone, surface 
markers were stained, cells perm-fixed, and GR stained with D8H2-Alexa 488 or 5E4-FITC monoclonal antibodies 
(G-5-Alexa 488 shown in Fig. 4b). 
(E) WT mouse thymocytes were incubated for 20 min in medium containing 10-7 M corticosterone, washed twice 
and incubated in steroid-free medium, and collected at the indicated times. One aliquot was fixed in 1% 
formaldehyde and ChIP-qPCR performed to quantitate GR binding to the Tsc22d3 (Gilz) gene promoter. Another 
aliquot was perm-fixed, GR stained, and counted by flow cytometry.





























































































































Supplementary Figure 3. Dose-response of perm-fixed GFP-GR mouse thymocytes and flow cytometry gating 
strategies.
(a) Primary thymocytes from GFP-GR knockin mice were incubated in the indicated corticosterone concentrations for 20 
min, fixed or perm-fixed, and cells measured by flow cytometry.
(b) Flow cytometry gating strategy for blood and spleen lymphocytes (adult mouse blood sample shown).

















































Figur  S3. Dose-response of perm-fixed GFP-GR mouse thymocytes and flow cytometry gating strategies. Related 
to Figures 6 and 7. 
(A) Primary thymocytes from GFP-GR knockin mice were incubated in the indicated corticosterone concentrations 
for 20 min, fixed or perm-fixed, and cells measured by flow cytometry. 
(B) Flow cytometry gating strategy for blood and spleen lymphocytes (adult mouse blood sample shown). 
(C) Flow cytometry gating strategy for thymocyte subsets (neonatal mouse thymus shown). 
